Brexit: first aid for Pharma

Brexit, if and when it happens, may have a substantial impact on the UK pharmaceutical industry. Although related issues will also have an impact upon many aspects of that industry, this note focuses on the key regulatory implications.

"First Aid for Pharma" focuses on UK pharmaceutical companies that wish to continue to operate within the EU structure in a post-Brexit world. 

Find out more here.

Back